Skip to main content

Advertisement

SpringerLink
Log in

Aspirin for patients after TIPS: an old dog with new tricks?

  • Letter to the Editor
  • Published:
Hepatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Seifert LL, Schindler P, Sturm L, et al. Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study. Hepatol Int. 2022. https://doi.org/10.1007/s12072-022-10330-x

    Article  PubMed  Google Scholar 

  2. Davidson KW, Barry MJ, US Preventive Services Task Force, et al. Aspirin use to prevent cardiovascular disease: US preventive services task force recommendation statement. JAMA. 2022;327:1577–1584

    Article  Google Scholar 

  3. Huang Y, Lee C, Yang S, et al. Statins reduce the risk of cirrhosis and its decompensation in chronic hepatitis B patients: a nationwide cohort study. Am J Gastroenterol. 2016;111:976–985

    Article  CAS  Google Scholar 

  4. Singh J, Wozniak A, Cotler SJ, et al. Combined use of aspirin and statin is associated with a decreased incidence of hepatocellular carcinoma. J Clin Gastroenterol. 2022;56:369–373

    Article  CAS  Google Scholar 

  5. Angeli P, Bernardi M, Villanueva C, et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, Gansu, China

    Jitao Wang & Xiaolong Qi

  2. Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People’s Hospital of Hebei Medical University, Xingtai, 054001, Hebei, China

    Jitao Wang, Dengxiang Liu & Shubo Chen

Authors
  1. Jitao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dengxiang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shubo Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaolong Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JW: conceptualized the study; JW: wrote the manuscript; DL, SC and XQ: critically reviewed the manuscript for important intellectual content. All authors reviewed the manuscript and approved the final submission.

Corresponding author

Correspondence to Xiaolong Qi.

Ethics declarations

Competing interest

Jitao Wang, Dengxiang Liu, Shubo Chen, Xiaolong Qi declare no competing interests in this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Liu, D., Chen, S. et al. Aspirin for patients after TIPS: an old dog with new tricks?. Hepatol Int 16, 1244–1245 (2022). https://doi.org/10.1007/s12072-022-10383-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-022-10383-y

Search

Navigation